Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trials.

Pazan F, Petrovic M, Cherubini A, Onder G, Cruz-Jentoft AJ, Denkinger M, van der Cammen TJM, Stevenson JM, Ibrahim K, Rajkumar C, Bakken MS, Baeyens JP, Crome P, Frühwald T, Gallaghar P, Guðmundsson A, Knol W, O'Mahony D, Pilotto A, Rönnemaa E, Serra-Rexach JA, Soulis G, van Marum RJ, Ziere G, Mair A, Burkhardt H, Neumann-Podczaska A, Wieczorowska-Tobis K, Fernandes MA, Gruner H, Dallmeier D, Beuscart JB, van der Velde N, Wehling M

Open source

DOI
10.1007/s00228-020-02951-8
Published
2021 Jan
Container
European journal of clinical pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00228-020-02951-8,
  title = {Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trials.},
  author = {Pazan F and Petrovic M and Cherubini A and Onder G and Cruz-Jentoft AJ and Denkinger M and van der Cammen TJM and Stevenson JM and Ibrahim K and Rajkumar C and Bakken MS and Baeyens JP and Crome P and Frühwald T and Gallaghar P and Guðmundsson A and Knol W and O'Mahony D and Pilotto A and Rönnemaa E and Serra-Rexach JA and Soulis G and van Marum RJ and Ziere G and Mair A and Burkhardt H and Neumann-Podczaska A and Wieczorowska-Tobis K and Fernandes MA and Gruner H and Dallmeier D and Beuscart JB and van der Velde N and Wehling M},
  year = {2021},
  journal = {European journal of clinical pharmacology},
  doi = {10.1007/s00228-020-02951-8},
  url = {https://doi.org/10.1007/s00228-020-02951-8}
}

RIS

TY  - JOUR
TI  - Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trials.
AU  - Pazan F
AU  - Petrovic M
AU  - Cherubini A
AU  - Onder G
AU  - Cruz-Jentoft AJ
AU  - Denkinger M
AU  - van der Cammen TJM
AU  - Stevenson JM
AU  - Ibrahim K
AU  - Rajkumar C
AU  - Bakken MS
AU  - Baeyens JP
AU  - Crome P
AU  - Frühwald T
AU  - Gallaghar P
AU  - Guðmundsson A
AU  - Knol W
AU  - O'Mahony D
AU  - Pilotto A
AU  - Rönnemaa E
AU  - Serra-Rexach JA
AU  - Soulis G
AU  - van Marum RJ
AU  - Ziere G
AU  - Mair A
AU  - Burkhardt H
AU  - Neumann-Podczaska A
AU  - Wieczorowska-Tobis K
AU  - Fernandes MA
AU  - Gruner H
AU  - Dallmeier D
AU  - Beuscart JB
AU  - van der Velde N
AU  - Wehling M
PY  - 2021
JO  - European journal of clinical pharmacology
DO  - 10.1007/s00228-020-02951-8
UR  - https://doi.org/10.1007/s00228-020-02951-8
ER  - 

APA

F, P., M, P., A, C., G, O., AJ, C., M, D., TJM, V. D. C., JM, S., K, I., C, R., MS, B., JP, B., P, C., T, F., P, G., A, G., W, K., D, O., A, P., E, R., JA, S., G, S., RJ, V. M., G, Z., A, M., H, B., A, N., K, W., MA, F., H, G., D, D., JB, B., N, V. D. V., & M, W. (2021). Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trials.. European journal of clinical pharmacology. https://doi.org/10.1007/s00228-020-02951-8

Source records